Literature DB >> 21316362

GDNF modifies reactive astrogliosis allowing robust axonal regeneration through Schwann cell-seeded guidance channels after spinal cord injury.

Ling-Xiao Deng1, Jianguo Hu, Naikui Liu, Xiaofei Wang, George M Smith, Xuejun Wen, Xiao-Ming Xu.   

Abstract

Reactive astrogliosis impedes axonal regeneration after injuries to the mammalian central nervous system (CNS). Here we report that glial cell line-derived neurotrophic factor (GDNF), combined with transplanted Schwann cells (SCs), effectively reversed the inhibitory properties of astrocytes at graft-host interfaces allowing robust axonal regeneration, concomitant with vigorous migration of host astrocytes into SC-seeded semi-permeable guidance channels implanted into a right-sided spinal cord hemisection at the 10th thoracic (T10) level. Within the graft, migrated host astrocytes were in close association with regenerated axons. Astrocyte processes extended parallel to the axons, implying that the migrated astrocytes were not inhibitory and might have promoted directional growth of regenerated axons. In vitro, GDNF induced migration of SCs and astrocytes toward each other in an astrocyte-SC confrontation assay. GDNF also enhanced migration of astrocytes on a SC monolayer in an inverted coverslip migration assay, suggesting that this effect is mediated by direct cell-cell contact between the two cell types. Morphologically, GDNF administration reduced astrocyte hypertrophy and induced elongated process extension of these cells, similar to what was observed in vivo. Notably, GDNF treatment significantly reduced production of glial fibrillary acidic protein (GFAP) and chondroitin sulfate proteoglycans (CSPGs), two hallmarks of astrogliosis, in both the in vivo and in vitro models. Thus, our study demonstrates a novel role of GDNF in modifying spinal cord injury (SCI)-induced astrogliosis resulting in robust axonal regeneration in adult rats.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21316362      PMCID: PMC3100372          DOI: 10.1016/j.expneurol.2011.02.001

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  57 in total

Review 1.  Role of astrocytes in the clearance of excess extracellular potassium.

Authors:  W Walz
Journal:  Neurochem Int       Date:  2000-04       Impact factor: 3.921

2.  Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.

Authors:  J H Kordower; M E Emborg; J Bloch; S Y Ma; Y Chu; L Leventhal; J McBride; E Y Chen; S Palfi; B Z Roitberg; W D Brown; J E Holden; R Pyzalski; M D Taylor; P Carvey; Z Ling; D Trono; P Hantraye; N Déglon; P Aebischer
Journal:  Science       Date:  2000-10-27       Impact factor: 47.728

3.  GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo.

Authors:  E Arenas; M Trupp; P Akerud; C F Ibáñez
Journal:  Neuron       Date:  1995-12       Impact factor: 17.173

4.  Migration of oligodendrocyte precursors on astrocytes and meningeal cells.

Authors:  J Fok-Seang; G A Mathews; C ffrench-Constant; J Trotter; J W Fawcett
Journal:  Dev Biol       Date:  1995-09       Impact factor: 3.582

Review 5.  Regeneration in the adult mammalian CNS: guided by development.

Authors:  I Aubert; J L Ridet; F H Gage
Journal:  Curr Opin Neurobiol       Date:  1995-10       Impact factor: 6.627

6.  Axonal regeneration into Schwann cell-seeded guidance channels grafted into transected adult rat spinal cord.

Authors:  X M Xu; V Guénard; N Kleitman; M B Bunge
Journal:  J Comp Neurol       Date:  1995-01-02       Impact factor: 3.215

7.  Ciliary neurotrophic factor stimulates the expression of glial fibrillary acidic protein by brain astrocytes in vivo.

Authors:  R E Clatterbuck; D L Price; V E Koliatsos
Journal:  J Comp Neurol       Date:  1996-06-10       Impact factor: 3.215

8.  GDNF is an age-specific survival factor for sensory and autonomic neurons.

Authors:  A Buj-Bello; V L Buchman; A Horton; A Rosenthal; A M Davies
Journal:  Neuron       Date:  1995-10       Impact factor: 17.173

9.  Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat.

Authors:  A Logan; M Berry; A M Gonzalez; S A Frautschy; M B Sporn; A Baird
Journal:  Eur J Neurosci       Date:  1994-03-01       Impact factor: 3.386

10.  Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF.

Authors:  R W Oppenheim; L J Houenou; J E Johnson; L F Lin; L Li; A C Lo; A L Newsome; D M Prevette; S Wang
Journal:  Nature       Date:  1995-01-26       Impact factor: 49.962

View more
  42 in total

1.  Glial Cell Line-Derived Neurotrophic Factor-Transfected Placenta-Derived Versus Bone Marrow-Derived Mesenchymal Cells for Treating Spinal Cord Injury.

Authors:  Yao Lu; Hui Gao; Man Zhang; Bing Chen; Huilin Yang
Journal:  Med Sci Monit       Date:  2017-04-14

2.  Nerve regeneration restores supraspinal control of bladder function after complete spinal cord injury.

Authors:  Yu-Shang Lee; Ching-Yi Lin; Hai-Hong Jiang; Marc Depaul; Vernon W Lin; Jerry Silver
Journal:  J Neurosci       Date:  2013-06-26       Impact factor: 6.167

3.  Transforming growth factor α transforms astrocytes to a growth-supportive phenotype after spinal cord injury.

Authors:  Robin E White; Meghan Rao; John C Gensel; Dana M McTigue; Brian K Kaspar; Lyn B Jakeman
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

Review 4.  Schwann cell transplantation and descending propriospinal regeneration after spinal cord injury.

Authors:  Ling-Xiao Deng; Chandler Walker; Xiao-Ming Xu
Journal:  Brain Res       Date:  2014-09-26       Impact factor: 3.252

5.  Bisperoxovanadium Mediates Neuronal Protection through Inhibition of PTEN and Activation of PI3K/AKT-mTOR Signaling after Traumatic Spinal Injuries.

Authors:  Chandler L Walker; Xiangbing Wu; Nai-Kui Liu; Xiao-Ming Xu
Journal:  J Neurotrauma       Date:  2019-03-28       Impact factor: 5.269

Review 6.  Combination therapies in the CNS: engineering the environment.

Authors:  Dylan A McCreedy; Shelly E Sakiyama-Elbert
Journal:  Neurosci Lett       Date:  2012-02-17       Impact factor: 3.046

7.  Blockade of Neuroglobin Reduces Protection of Conditioned Medium from Human Mesenchymal Stem Cells in Human Astrocyte Model (T98G) Under a Scratch Assay.

Authors:  Eliana Baez-Jurado; Gina Guio Vega; Gjumrakch Aliev; Vadim V Tarasov; Paula Esquinas; Valentina Echeverria; George E Barreto
Journal:  Mol Neurobiol       Date:  2017-03-22       Impact factor: 5.590

8.  Aquaporin-4 mitigates retrograde degeneration of rubrospinal neurons by facilitating edema clearance and glial scar formation after spinal cord injury in mice.

Authors:  Qi Wu; Yong-Jie Zhang; Jun-Ying Gao; Xiu-Miao Li; Hui Kong; Yi-Ping Zhang; Ming Xiao; Christopher B Shields; Gang Hu
Journal:  Mol Neurobiol       Date:  2014-01-04       Impact factor: 5.590

9.  Astroglial-derived periostin promotes axonal regeneration after spinal cord injury.

Authors:  Chung-Hsuan Shih; Michelle Lacagnina; Kelly Leuer-Bisciotti; Christoph Pröschel
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

10.  A novel growth-promoting pathway formed by GDNF-overexpressing Schwann cells promotes propriospinal axonal regeneration, synapse formation, and partial recovery of function after spinal cord injury.

Authors:  Ling-Xiao Deng; Ping Deng; Yiwen Ruan; Zao Cheng Xu; Nai-Kui Liu; Xuejun Wen; George M Smith; Xiao-Ming Xu
Journal:  J Neurosci       Date:  2013-03-27       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.